{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T03:08:11Z","timestamp":1767236891734,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006244","name":"Stichting Kinderen Kankervrij","doi-asserted-by":"publisher","award":["15","15"],"award-info":[{"award-number":["15","15"]}],"id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1038\/s41375-021-01128-1","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T16:09:24Z","timestamp":1611331764000},"page":"2403-2406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4030-3228","authenticated-orcid":false,"given":"Bianca F.","family":"Goemans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanne","family":"Noort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein","family":"Blink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8751-9216","authenticated-orcid":false,"given":"Yong-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan T. C. J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9273-6258","authenticated-orcid":false,"given":"Jacobus P.","family":"van Wouwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertjan","family":"Kaspers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0339-6816","authenticated-orcid":false,"given":"Valerie","family":"de Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter J.","family":"Kollen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-3763","authenticated-orcid":false,"given":"Vincent H. J.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja A.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian M.","family":"Zwaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"1128_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","volume":"355","author":"H Hasle","year":"2000","unstructured":"Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome. Lancet. 2000;355:165\u20139.","journal-title":"Lancet"},{"key":"1128_CR2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405.","journal-title":"Blood"},{"key":"1128_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/bjh.12041","volume":"159","author":"AS Gamis","year":"2012","unstructured":"Gamis AS, Smith FO. Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder. Br J Haematol. 2012;159:277\u201387.","journal-title":"Br J Haematol"},{"key":"1128_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.hoc.2009.11.009","volume":"24","author":"CM Zwaan","year":"2010","unstructured":"Zwaan CM, Reinhardt D, Hitzler J, Vyas P. Acute leukemias in children with Down syndrome. Hematol Oncol Clin N Am. 2010;24:19\u201334.","journal-title":"Hematol Oncol Clin N Am"},{"key":"1128_CR5","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1182\/blood-2003-01-0013","volume":"101","author":"JK Hitzler","year":"2003","unstructured":"Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood. 2003;101:4301\u20134.","journal-title":"Blood"},{"key":"1128_CR6","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1182\/bloodadvances.2018018945","volume":"2","author":"M Flasinski","year":"2018","unstructured":"Flasinski M, Scheibke K, Zimmermann M, Creutzig U, Reinhardt K, Verwer F, et al. Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD prevention 2007 study. Blood Adv. 2018;2:1532\u201340.","journal-title":"Blood Adv"},{"key":"1128_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11899-016-0338-x","volume":"11","author":"N Bhatnagar","year":"2016","unstructured":"Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I. Transient abnormal myelopoiesis and AML in Down syndrome: an update. Curr Hematol Malig Rep. 2016;11:333\u201341.","journal-title":"Curr Hematol Malig Rep"},{"key":"1128_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/bjh.15390","volume":"182","author":"O Tunstall","year":"2018","unstructured":"Tunstall O, Bhatnagar N, James B, Norton A, O\u2019Marcaigh AS, Watts T, et al. Guidelines for the investigation and management of transient leukaemia of Down syndrome. Br J Haematol. 2018;182:200\u201311.","journal-title":"Br J Haematol"},{"key":"1128_CR9","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/ajmg.a.61748","volume":"182","author":"M Orozco-Vela","year":"2020","unstructured":"Orozco-Vela M, Corona-Rivera A, Cruz-Osorio RM, Mendoza-Maldonado L, Marquez-Mora A, Barba-Barba CC, et al. Complete blood count differences in a cohort of Down syndrome neonates with transient abnormal myelopoiesis screened for GATA1 pathogenic variants. Am J Med Genet A. 2020;182:2085\u201393.","journal-title":"Am J Med Genet A"},{"key":"1128_CR10","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1182\/blood-2011-03-342774","volume":"118","author":"KA Alford","year":"2011","unstructured":"Alford KA, Reinhardt K, Garnett C, Norton A, Bohmer K, von Neuhoff C, et al. Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia. Blood. 2011;118:2222\u201338.","journal-title":"Blood"},{"key":"1128_CR11","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1182\/blood-2013-07-515148","volume":"122","author":"I Roberts","year":"2013","unstructured":"Roberts I, Alford K, Hall G, Juban G, Richmond H, Norton A, et al. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood. 2013;122:3908\u201317.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-021-01128-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-021-01128-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-021-01128-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:41:54Z","timestamp":1684618914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01128-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1128"],"URL":"https:\/\/doi.org\/10.1038\/s41375-021-01128-1","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"type":"print","value":"0887-6924"},{"type":"electronic","value":"1476-5551"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"6 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}